Glucotrack, inc. provides development update on its gen 2 non-invasive glucose monitor

Rutherford, nj and or yehuda, israel, june 22, 2022 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a non-invasive device and digital health platform for measuring glucose levels in people with type 2 diabetes and prediabetes, announced today that it has provided an update on the development of glucotrack 2.0 (or “gen 2”).
GCTK Ratings Summary
GCTK Quant Ranking